Insiders · Profile

Hippel James

Chief Financial Officer at Bio-Techne. Filing since 1 May 2019. CIK 0001603594

Company
Date
Role
Action
Shares
Amount
Of holding
2 Nov 2021
Chief Financial Officer
Sold, plan not stated
200
$105.02K
1.8%
1 Nov 2021
Chief Financial Officer
Sold, plan not stated
8,822
$4.64M
45.1%
29 Oct 2021
Chief Financial Officer
Sold, plan not stated
662
$347.70K
5.8%
28 Oct 2021
Chief Financial Officer
Sold, plan not stated
100
$52.52K
0.9%
2 Sep 2021
Chief Financial Officer
Sold, plan not stated
10,000
$5.07M
48.0%
9 Aug 2021
Chief Financial Officer
Sold, plan not stated
10,000
$4.79M
48.0%
12 Jul 2021
Chief Financial Officer
Sold, plan not stated
10,000
$4.57M
52.3%
7 Jun 2021
Chief Financial Officer
Sold, plan not stated
9,942
$4.19M
52.1%
12 Feb 2021
Chief Financial Officer
Sold, plan not stated
10,000
$4.00M
52.3%
11 Jan 2021
Chief Financial Officer
Sold, plan not stated
10,000
$3.34M
52.3%
11 Nov 2020
Chief Financial Officer
Sold, plan not stated
7,391
$2.27M
44.7%
9 Nov 2020
Chief Financial Officer
Sold, plan not stated
3,600
$1.12M
28.3%
5 Nov 2020
Chief Financial Officer
Sold, plan not stated
8,809
$2.52M
49.1%
4 Nov 2020
Chief Financial Officer
Sold, plan not stated
7,100
$1.95M
43.7%
7 Jul 2020
Chief Financial Officer
Sold, plan not stated
2,577
$699.48K
21.7%
6 Jul 2020
Chief Financial Officer
Sold, plan not stated
21,502
$5.84M
69.8%
22 Nov 2019
Chief Financial Officer
Sold, plan not stated
23,651
$5.10M
71.8%
21 Nov 2019
Chief Financial Officer
Sold, plan not stated
11,349
$2.44M
54.9%
1 May 2019
Chief Financial Officer
Sold, plan not stated
35,000
$7.11M
88.9%
19 decisions on file.